Fmr. FDA chief Dr. Scott Gottlieb: The issue isn't just vaccine hesitancy, but accessibility
It's been a year since the World Health Organization declared the coronavirus a worldwide pandemic. Nearly 33 million Americans are now fully vaccinated. That's about 13 percent of all U.S. adults. Dr. Scott Gottlieb, former FDA commissioner, joins ‘The News with Shepard Smith’ to talk about what the current administration needs to do to make the vaccine more accessible to everyone. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi
President Joe Biden will meet his goal of vaccinating 100 million Americans in his first 100 days in office early, according to Dr. Scott Gottlieb.
“We’ll get 100 million Americans vaccinated probably by early April,” Gottlieb, who was FDA chief during the Trump administration, predicted. Biden’s 100th day in office is April 30.
While there is currently not enough supply of Covid vaccines to meet demand, the nation will soon have the exact opposite problem. Earlier Wednesday, Biden announced plans to buy another 100 million doses of Johnson & Johnson’s single-shot vaccine. Added to the doses from Pfizer and Moderna, it is more than enough supply to vaccinate every American.
Gottlieb said that he thinks “the bigger issue” will be when demand drops off. In order to stimulate demand in the U.S., he told CNBC’s “The News with Shepard Smith,” officials must make the vaccine “more accessible,” and that includes running clinics where people don’t have to sign-up for a vaccine ahead of time.
Nearly 33 million Americans are now fully vaccinated, that’s roughly 13% of all U.S. adults, according to the Centers for Disease Control and Prevention. The agency released new guidance Monday for those vaccinated Americans, but Gottlieb told host Shepard Smith that the guidance is too narrow.
“I think we need to prescribe a pathway forward, where people can start to resume their normal lives safely, and give people guidance to do that, and not be so prescriptive,” Gottlieb said.
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео Fmr. FDA chief Dr. Scott Gottlieb: The issue isn't just vaccine hesitancy, but accessibility канала CNBC Television
President Joe Biden will meet his goal of vaccinating 100 million Americans in his first 100 days in office early, according to Dr. Scott Gottlieb.
“We’ll get 100 million Americans vaccinated probably by early April,” Gottlieb, who was FDA chief during the Trump administration, predicted. Biden’s 100th day in office is April 30.
While there is currently not enough supply of Covid vaccines to meet demand, the nation will soon have the exact opposite problem. Earlier Wednesday, Biden announced plans to buy another 100 million doses of Johnson & Johnson’s single-shot vaccine. Added to the doses from Pfizer and Moderna, it is more than enough supply to vaccinate every American.
Gottlieb said that he thinks “the bigger issue” will be when demand drops off. In order to stimulate demand in the U.S., he told CNBC’s “The News with Shepard Smith,” officials must make the vaccine “more accessible,” and that includes running clinics where people don’t have to sign-up for a vaccine ahead of time.
Nearly 33 million Americans are now fully vaccinated, that’s roughly 13% of all U.S. adults, according to the Centers for Disease Control and Prevention. The agency released new guidance Monday for those vaccinated Americans, but Gottlieb told host Shepard Smith that the guidance is too narrow.
“I think we need to prescribe a pathway forward, where people can start to resume their normal lives safely, and give people guidance to do that, and not be so prescriptive,” Gottlieb said.
» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC
https://www.cnbc.com/select/best-credit-cards/
#CNBC
#CNBCTV
Видео Fmr. FDA chief Dr. Scott Gottlieb: The issue isn't just vaccine hesitancy, but accessibility канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Opening Bell, November 4, 2022NCAA student payment deal former creates big liability issues, says TD Ameritrade CEO Joe MogliaBreaking down shares of Hilton, Expedia and Match GroupLightning Round: The lithium group is played out, says Jim CramerRaymond James' Sunaina Sinha Haldea: There's more hope on the horizon for dealmakingOptions Action: What to expect from Dell next weekLockheed Martin sees record order volume in 2022 as earnings beat estimatesPiper Sandler's Harsh Kumar on what to expect from Nvidia earningsLadner: Utilities and tech sectors are ripe for additional investmentThere's room for more than one beneficiary in the AI chips space, says KeyBanc's John VinhStop Trading: Wedbush raises Apple price target to $275Final Trades: Nasdaq, Archer-Daniels-Midland & COPXJensen Huang rises on billionaires list after strong Nvidia earningsNothing wrong with market leaders like Nvidia continuing to lead, says Trade Idea's Michael NaussFreightWaves: Excess capacity is driving softness in freight marketWe are focused on our organic roadmap, says Box CEOClean Start: This clean-tech startup transforms carbon emissions into vodkaSEC approves spot Ether ETFsApple is a top teen pick, according to a Piper Sandler surveyChart of the Day: LululemonNvidia is simply much bigger than a semiconductor company, says Jim Cramer